Plato Investment Management’s CureVac CVAC Stock Holding History

Plato Investment Management’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,062	Closed	-$30.2K	–	526
2025 Q4	$30.2K	Sell	7,062 -14,653	-67%	-$75.1K	﹤0.01%	451
2025 Q3	$116K	Hold	21,715	–	–	0.01%	415
2025 Q2	$117K	Sell	21,715 -7,780	-26%	-$30.9K	0.01%	419
2025 Q1	$84K	Buy	+29,495	New	+$103K	0.01%	431

Plato Investment Management's CVAC Position: Q1 2026 in Review

Plato Investment Management sold out of CureVac (CVAC) in Q1 2026, closing a stake of 7,062 shares — an estimated $30.2K sold.

Plato Investment Management first reported a position in CVAC in Q1 2025 and held it in 4 quarters. The position peaked at $117K in Q2 2025. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.

Plato Investment Management reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
Plato Investment Management sold 7,062 CureVac shares in Q1 2026, an estimated $30.2K.
Plato Investment Management first reported a position in CureVac in Q1 2025 and held it in 4 quarters.
Plato Investment Management's CureVac position peaked at $117K in Q2 2025.
0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.

Based on Plato Investment Management's 13F filing for Q1 2026, filed 5 May 2026.